By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Personalized medicine software company MediSapiens has raised $1 million in seed funding from Veraventure, ETF III, VTT Ventures, and Lifeline Ventures.

The Helsinki-based company provides a software database platform that provides genomic data about cancer and cancer treatments that can be used to develop personalized therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: caution urged in use of gene drives, and more.

NIH's Sally Rockey examines the tapped and untapped potential of the NIH peer reviewer pool.

PLOS Biology has asked researchers how they envision the future of genetics and genomics.

Representative Lamar Smith brings back a provision to require the National Science Foundation to certify that each study it funds is "in the national interest."